Report of Foreign Issuer (6-k)
November 15 2016 - 9:24AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November, 2016
Commission File Number: 001-15152
SYNGENTA AG
(Translation of registrant’s name into
English)
Schwarzwaldallee 215
4058 Basel
Switzerland
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Disclosure:
|
“Syngenta receives approval for breakthrough
fungicide
ADEPIDYN™ in Argentina”
|
Herewith we furnish a press release related to Syngenta AG. The
full text of the press release is the following:
# # #
Syngenta International AG
Media Office
CH-4002 Basel
Switzerland
Tel: +41 61 323 2323
Fax: +41 61 323 2424
www.syngenta.com
|
Media contacts:
Leandro Conti
Switzerland +41 61 323 2323
Paul Minehart
USA +1 202 737 8913
|
Analyst/Investor contacts:
Jennifer Gough
Switzerland +41 61 323 5059
USA +1 202 737 6521
|
Basel, Switzerland, November 15, 2016
Syngenta receives approval for breakthrough fungicide ADEPIDYN™
in Argentina
|
·
|
First registration of a product based on ADEPIDYN™
|
|
·
|
Global peak sales potential estimated at more than $750 million
|
|
·
|
ADEPIDYN™ based products to be marketed under the MIRAVIS™ brand
|
Syngenta announced today that MIRAVIS™
Duo, a combination of ADEPIDYN™ and difenoconazole, has been approved by SENASA (regulatory authority in Argentina), for
use on soybean for late cycle diseases. This is the first registration for a product based on ADEPIDYN™, a new fungicide
belonging to the carboxamide chemical class.
ADEPIDYN™
provides a step change in leaf spot disease management and delivers excellent control of powdery mildew. It is highly effective
on difficult-to-control diseases such as Fusarium head blight and moulds which cause severe damage to the crop.
Syngenta
is currently developing several ADEPIDYN™ based products to address various disease management challenges in soybean, wheat,
corn, canola, vegetables and specialty crops around the world.
Jon Parr, President Global Crop Protection,
Syngenta, said “MIRAVIS™ Duo builds on our strong fungicide heritage including ELATUS™ and AMISTAR
®
Technology. By continuing to deliver industry-leading innovation to growers, we are strengthening our global leadership in fungicides.”
First sales
of MIRAVIS™ Duo are expected in the 2016/2017 soybean season in Argentina.
Regulatory approvals are pending in several
other markets.
About Syngenta
Syngenta is a leading agriculture company
helping to improve global food security by enabling millions of farmers to make better use of available resources. Through world
class science and innovative crop solutions, our 28,000 people in over 90 countries are working to transform how crops are grown.
We are committed to rescuing land from degradation, enhancing biodiversity and revitalizing rural communities. To learn more visit
www.syngenta.com
and
www.goodgrowthplan.com
. Follow
us on Twitter
®
at
www.twitter.com/Syngenta
.
Syngenta – November 15, 2016 / Page
1
of 2
Cautionary Statement Regarding
Forward-Looking Statements
This document contains forward-looking
statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’,
‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar
expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially
from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for
information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements
to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer
or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta
AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.
Syngenta – November 15, 2016 / Page
2
of 2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
SYNGENTA AG
|
|
|
|
Date:
|
November 15, 2016
|
|
By:
|
/s/ Dr. Tobias Meili
|
|
|
|
|
Name:
|
Dr. Tobias Meili
|
|
|
|
|
Title:
|
Head Corporate Legal Affairs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Markus Widmer
|
|
|
|
|
Name:
|
Markus Widmer
|
|
|
|
|
Title:
|
Legal Counsel
|
|
|
|
|
|
|
Syngenta (NYSE:SYT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Syngenta (NYSE:SYT)
Historical Stock Chart
From Apr 2023 to Apr 2024